Inhibitory Effect of Mitoxantrone on Collagen Synthesis in Dermal Fibroblasts

Kyung-Il Kim1,2,3, Chang-Il Kwon3,4, Jeung-Hoon Lee5

  • 1Department of Dermatology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.

Annals of Dermatology
|June 20, 2022
PubMed
Abstract

Insights

Mitoxantrone reduces collagen synthesis in fibroblasts by inhibiting key signaling pathways and gene expression. This finding suggests its potential as a therapeutic for conditions involving excessive collagen production.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Biochemistry

Background:

  • Fibroblasts are crucial for skin structure through collagen production.
  • Imbalances in collagen synthesis, either decreased or excessive, lead to skin conditions like atrophy, wrinkles, and scars.

Purpose of the Study:

  • To elucidate the mechanism by which mitoxantrone influences collagen synthesis in fibroblasts.

Main Methods:

  • Fibroblasts were cultured and treated with mitoxantrone.
  • Collagen synthesis was assessed using reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis.
  • Collagen gel contraction assays were performed to evaluate functional effects.

Main Results:

  • Mitoxantrone suppressed type I collagen expression at both mRNA and protein levels.
  • The drug significantly inhibited collagen gel contraction.
  • Mitoxantrone interfered with transforming growth factor-beta (TGF-β)-induced SMAD3 phosphorylation and reduced LARP6 expression.

Conclusions:

  • Mitoxantrone mitigates collagen synthesis by inhibiting TGF-β/SMAD signaling and downregulating LARP6 in fibroblasts.
  • These mechanisms position mitoxantrone as a potential therapeutic for diseases characterized by collagen overproduction.